Header

PING Conference 2025 - Key takeaways

19 Jun 2025

This paper is part of our Sustainability Insights series following the 2025 PING Conference on Sustainability - What must Pharma do now? - bringing you expert perspectives and practical takeaways from key discussions shaping the future of businesses looking to address the threats and opportunities of sustainability in the life sciences sector. Thanks to Hertfordshire Futures for their great support of PING yet again.


On 12 May 2025, VWV welcomed over 100 leaders from across the pharmaceutical and life sciences sector to the historic Old Palace at Hatfield House for our flagship event – the 2025 PING Conference.

This year’s theme, “Sustainability – What must Pharma do now?”, brought together a diverse and highly engaged audience of business leaders, investors, NHS representatives, consultants, policy experts and industry innovators to explore one of the most pressing challenges facing the sector today: how to embed environmental sustainability as a core business imperative.

As the regulatory, financial, and reputational stakes rise – and as the NHS and global supply chains accelerate their own net zero commitments – sustainability is rapidly evolving to a central operational priority for the pharmaceutical and life sciences industry. Our speakers and panellists brought deep insight into this shifting landscape, covering the drivers for change and the practical strategies organisations can adopt to respond.

Below, is a collection of summaries of the sessions and a roundup of what our excellent speakers had to share at this year's conference. The PING conference is proudly supported by Hertfordshire Futures:

Session 1

Sustainability - Why must Pharma act now?

Session 2

Sustainability - The impact of regulatory pressures and flowdown from other industry players?

Session 3

Sustainability - How to work with the NHS?

Session 4

Sustainability as a strategic imperative to brand value, recruitment, consumer trust, and access to capital

Session 5

Sustainability - What steps can you actually take?

Session 6

Working with suppliers to address Scope 3 emissions?

Session 7

Sustainable buildings in Pharma

Session 8

Sustainability in Pharma - So what role does AI have to play?

For more information, please contact Paul Gershlick in our Pharmaceuticals and Life Sciences team. 

Sign up to our newsletter and law briefs

To keep abreast of legal developments in your industry or generally, please subscribe to our law briefs.